Kazuhito Misawa
YOU?
Author Swipe
View article: A case of gastrointestinal amyloidosis diagnosed by characteristic endoscopic findings and computed tomography
A case of gastrointestinal amyloidosis diagnosed by characteristic endoscopic findings and computed tomography Open
View article: Efficacy and safety of pleurodesis for lung cancer patients with interstitial lung disease
Efficacy and safety of pleurodesis for lung cancer patients with interstitial lung disease Open
Pleurodesis is considered to be one of the treatment options against MPE in patients with ILD. However, two cases of ARDS were observed; thus, clinicians should carefully consider the indication of pleurodesis in the patients who had the r…
View article: A rapidly progressive case of tuberculous pleurisy and pericarditis in a patient with non-small cell lung cancer that developed one month after receiving pembrolizumab monotherapy
A rapidly progressive case of tuberculous pleurisy and pericarditis in a patient with non-small cell lung cancer that developed one month after receiving pembrolizumab monotherapy Open
View article: Durvalumab plus platinum-etoposide chemotherapy for extensive-stage small cell lung cancer: a retrospective real-world study
Durvalumab plus platinum-etoposide chemotherapy for extensive-stage small cell lung cancer: a retrospective real-world study Open
Durvalumab plus PE in patients with ES-SCLC showed good efficacy and safety according to our real-world data, suggesting that this treatment is well tolerated in clinical practice, even in elderly patients and those with poor PS.
View article: Successful Treatment with Definitive Concurrent Chemoradiotherapy Followed by Durvalumab Maintenance Therapy in a Patient with Tracheal Adenoid Cystic Carcinoma
Successful Treatment with Definitive Concurrent Chemoradiotherapy Followed by Durvalumab Maintenance Therapy in a Patient with Tracheal Adenoid Cystic Carcinoma Open
Adenoid cystic carcinoma (ACC) is a rare type of malignant tracheal tumor originating from the secretory glands. Complete surgical resection is the current standard of care for tracheal ACC. However, there have been few case reports of che…
View article: Alectinib-Induced Severe Hemolytic Anemia in a Patient with ALK-Positive Non-Small Cell Lung Cancer: A Case Report
Alectinib-Induced Severe Hemolytic Anemia in a Patient with ALK-Positive Non-Small Cell Lung Cancer: A Case Report Open
Alectinib is a selective anaplastic lymphoma kinase (ALK) tyrosine kinase inhibitor as standard therapy for ALK-rearranged non-small cell lung cancer (NSCLC). Hemolytic anemia is considered as a rare but significant adverse event with alec…
View article: P8‐173: The evaluation of the relationship between the plasma concentration and toxicities and effects using divided erlotinib FOR EGFR‐mutant NSCLC
P8‐173: The evaluation of the relationship between the plasma concentration and toxicities and effects using divided erlotinib FOR EGFR‐mutant NSCLC Open
Osimertinib was stated in September as the 5th-line chemotherapy and the EGFR mutation-positive tumor shrank soon.